Literature DB >> 16385142

Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry.

Raphaëlle Winsky-Sommerer1, Benjamin Boutrel, Luis de Lecea.   

Abstract

The hypocretins (also know as orexins) are two neuropeptides now commonly described as critical components for maintaining and regulating the stability of arousal. Several lines of evidence have raised the hypothesis that hypocretin-producing neurons are part of the circuitries that mediate the hypothalamic response to acute stress. New data indicate that the corticotrophin-releasing factor (CRF) peptidergic system directly innervates hypocretin-expressing neurons. CRF depolarizes hypocretin neurons, and this effect is blocked by a CRF-R1 antagonist. Furthermore, activation of hypocretinergic neurons by stress is impaired in CRF-R1 knockout mice. These data suggest that CRF-R1 receptor mediates the stress-induced activation of the hypocretinergic system. A significant amount of evidence also indicates that hypocretin cells connect reciprocally to the CRF system. We propose that upon stressor stimuli, CRF activates the hypocretin system, which relays these signals to brain stem nuclei involved in the modulation of arousal as well as to the extended amygdala, a structure involved in the negative motivational state that drives addiction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16385142     DOI: 10.1385/MN:32:3:285

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  83 in total

Review 1.  The role of the striatopallidal and extended amygdala systems in drug addiction.

Authors:  G F Koob
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

Review 2.  Brain circuitry and the reinstatement of cocaine-seeking behavior.

Authors:  Peter W Kalivas; Krista McFarland
Journal:  Psychopharmacology (Berl)       Date:  2003-03-22       Impact factor: 4.530

3.  Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.

Authors:  J Hara; C T Beuckmann; T Nambu; J T Willie; R M Chemelli; C M Sinton; F Sugiyama; K Yagami; K Goto; M Yanagisawa; T Sakurai
Journal:  Neuron       Date:  2001-05       Impact factor: 17.173

4.  Fos expression in orexin neurons varies with behavioral state.

Authors:  I V Estabrooke; M T McCarthy; E Ko; T C Chou; R M Chemelli; M Yanagisawa; C B Saper; T E Scammell
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

5.  Orexin A activates leptin-responsive neurons in the arcuate nucleus.

Authors:  M Rauch; T Riediger; H A Schmid; E Simon
Journal:  Pflugers Arch       Date:  2000-09       Impact factor: 3.657

6.  Effects of orexin on cultured porcine adrenal medullary and cortex cells.

Authors:  Toru Nanmoku; Kazumasa Isobe; Takeshi Sakurai; Akihiro Yamanaka; Kazuhiro Takekoshi; Yasushi Kawakami; Katsutoshi Goto; Toshiaki Nakai
Journal:  Regul Pept       Date:  2002-03-15

Review 7.  Alcoholism: allostasis and beyond.

Authors:  George F Koob
Journal:  Alcohol Clin Exp Res       Date:  2003-02       Impact factor: 3.455

8.  Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice.

Authors:  Rose-Marie Karlsson; Andrew Holmes; Markus Heilig; Jacqueline N Crawley
Journal:  Pharmacol Biochem Behav       Date:  2005-01-25       Impact factor: 3.533

9.  Modulation of hypothalamic hypocretin/orexin mRNA expression by glucocorticoids.

Authors:  Alain Stricker-Krongrad; Bernard Beck
Journal:  Biochem Biophys Res Commun       Date:  2002-08-09       Impact factor: 3.575

10.  Hypothalamic orexin neurons regulate arousal according to energy balance in mice.

Authors:  Akihiro Yamanaka; Carsten T Beuckmann; Jon T Willie; Junko Hara; Natsuko Tsujino; Michihiro Mieda; Makoto Tominaga; Ken ichi Yagami; Fumihiro Sugiyama; Katsutoshi Goto; Masashi Yanagisawa; Takeshi Sakurai
Journal:  Neuron       Date:  2003-06-05       Impact factor: 17.173

View more
  51 in total

1.  Hypocretin receptor 2 antagonism dose-dependently reduces escalated heroin self-administration in rats.

Authors:  Brooke E Schmeichel; Estelle Barbier; Kaushik K Misra; Candice Contet; Joel E Schlosburg; Dimitri Grigoriadis; John P Williams; Camilla Karlsson; Caleb Pitcairn; Markus Heilig; George F Koob; Leandro F Vendruscolo
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

2.  Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA.

Authors:  Mark G LeSage; Jennifer L Perry; Catherine M Kotz; David Shelley; William A Corrigall
Journal:  Psychopharmacology (Berl)       Date:  2010-02-24       Impact factor: 4.530

3.  The orexin system regulates alcohol-seeking in rats.

Authors:  Andrew J Lawrence; Michael S Cowen; Hong-Ju Yang; Feng Chen; Brian Oldfield
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

4.  Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior.

Authors:  Benjamin Boutrel; Paul J Kenny; Sheila E Specio; Rémi Martin-Fardon; Athina Markou; George F Koob; Luis de Lecea
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-15       Impact factor: 11.205

Review 5.  The brain hypocretins and their receptors: mediators of allostatic arousal.

Authors:  Matthew E Carter; Jana Schaich Borg; Luis de Lecea
Journal:  Curr Opin Pharmacol       Date:  2009-02       Impact factor: 5.547

Review 6.  The hypocretins/orexins: integrators of multiple physiological functions.

Authors:  Jingcheng Li; Zhian Hu; Luis de Lecea
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

7.  Spontaneous activity, economy of activity, and resistance to diet-induced obesity in rats bred for high intrinsic aerobic capacity.

Authors:  Colleen M Novak; Carlos Escande; Paul R Burghardt; Minzhi Zhang; Maria Teresa Barbosa; Eduardo N Chini; Steven L Britton; Lauren G Koch; Huda Akil; James A Levine
Journal:  Horm Behav       Date:  2010-03-27       Impact factor: 3.587

Review 8.  Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking.

Authors:  Uri Shalev; Suzanne Erb; Yavin Shaham
Journal:  Brain Res       Date:  2009-07-23       Impact factor: 3.252

Review 9.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

10.  Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats.

Authors:  Jemma K Richards; Jeffrey A Simms; Pia Steensland; Sharif A Taha; Stephanie L Borgland; Antonello Bonci; Selena E Bartlett
Journal:  Psychopharmacology (Berl)       Date:  2008-05-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.